Dr. Eltayeb H. Elshiekh, MD

Dr. Elshiekh practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Elshiekh's NPI, 1245325257, was assigned on October 4, 2006. Dr. Elshiekh holds Michigan license 4301502947.

Dr. Elshiekh's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Elshiekh's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. The medical group on file is Medical Education Associates. Dmand AI also links Dr. Elshiekh to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elshiekh practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Elshiekh's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Elshiekh's licenses on file in 4 states: Michigan, Indiana, North Dakota and New York.

CMS data shows 355 Medicare services from Dr. Elshiekh across 5 procedure codes in 2024, for 150 Medicare patients. Medicare paid $26,472 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 150 Medicare patients who saw Dr. Elshiekh in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elshiekh's median patient age at 61, with 56% women.

In 2024, Dr. Elshiekh wrote 171 Medicare Part D claims for 42 patients. 86% of them were for generic drugs. CMS names the drug for 56 of them, across 2 drugs with 11 or more claims each, at $251 in total drug cost. In 2023, CMS named 44 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Elshiekh for performance year 2024, reported as part of a group. Dr. Elshiekh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Elshiekh from 2 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $90.